Prescribing PAH therapy off-label in pulmonary hypertension is not supported by rigorous clinical evidence.
A risk model has been developed and validated for hospital readmission within 30 days after AMI in older patients and has demonstrated moderate performance.
Consumption of sleeping pills is linked to a subsequent increase in the number of antihypertensive drugs taken among older adults.
Meta-analysis shows considerable evidence of the benefits of endovascular thrombectomy for survival during the first 90 days after acute ischemic stroke.
B. Braun Medical has launched the first Heparin 5000 USP Unit/0.5mL prefilled syringe with an attached safety needle for subcutaneous and intravenous use in the US.
Rates of osteoporosis screening and treatment are low in patients with recent stroke despite elevated risk for low-trauma fracture.
A panel of 4 clinicians with experience in pediatric pulmonology discuss current research findings and gaps in studies of pediatric obstructive sleep apnea, particularly regarding cardiovascular risk.
Three simple measurements may predict metabolic syndrome (MetS) in older patients.
Based on initial gains in health care access from the passage of the 2010 Patient Protection and ACA, the ACP offers recommendations on how to improve the law and achieve universal health care coverage.
The prognosis for patients with idiopathic pulmonary arterial hypertension is substantially worse than for patients with idiopathic PAH.
Complete fractional flow reserve-guided revascularization in patients with STEMI and multivessel disease did not affect final infarct size, LV function, or remodeling compared with culprit-only percutaneous coronary intervention.
Glucose screening during pregnancy can predict future cardiovascular (CV) risk in women with and without gestational diabetes, according to study results published in The Lancet Diabetes & Endocrinology. CV risk was found to be higher with abnormal glucose screening tests, but there was also increased CV risk in women with glucose concentrations at the upper…
The FDA has cleared KardiaMobile (AliveCor), a personal ECG device, for use in detecting bradycardia and tachycardia.
A recently published report describes the case of a 31-year-old African American female who experienced psychiatric symptoms after her dose of sacubitril/valsartan was increased.
Clinicians can promote community investment by helping to create the data and demand that will catalyze efforts to address the root causes of ill health.
The 2017 guidelines identified a group of children whose CV risk may have been underestimated using older guidelines.
The severity of lung disease in preterm infants with bronchopulmonary dysplasia and pulmonary hypertension undergoing cardiac catheterization did not correlate with mortality.
Being a younger age at diagnosis of type 2 diabetes is associated with greater risk for total mortality and mortality related to cardiovascular disease outcomes.
Increased educational debt appears to directly influence physician practice choice.
Red cell distribution width may help detect early incident PH in patients who are at high risk for PH development.